Evidence map›Paper›PMID 29302369›Full record

ArticleJournal of gastric cancer2017

Long-term Follow-up for Type 2 Diabetes Mellitus after Gastrectomy in Non-morbidly Obese Patients with Gastric Cancer: the Legitimacy of Onco-metabolic Surgery.

Tae-Hoon Lee, Chang Min Lee, Sungsoo Park, Do Hyun Jung, You Jin Jang, Jong-Han Kim, Seong-Heum Park, Young-Jae Mok

Open access · hybridAbstract read
In one paragraph

Article in Journal of gastric cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Type 2 diabetes in patients undergoing gastric cancer surgery: areas requiring disease-specific glycemic management.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Review
  4. Review
  5. Advances, breakthroughs, and challenges in gastric cancer surgery.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2023
    Article
  6. Article
  7. Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Does Reconstruction Type After Gastric Resection Matters for Type 2 Diabetes Improvement?Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2020
    Article
  17. Oncometabolic surgery: Emergence and legitimacy for investigation.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2020
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tae-Hoon LeeDepartment of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Chang Min LeeDepartment of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Sungsoo ParkDepartment of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Do Hyun JungDepartment of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
You Jin JangDepartment of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Jong-Han KimDepartment of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Seong-Heum ParkDepartment of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Young-Jae MokDepartment of Surgery, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
Korea University Medical Center · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study primarily aimed to investigate the short- and long-term remission rates of type 2 diabetes (T2D) in patients who underwent surgical treatment for gastric cancer, especially patients who were non-obese, and secondarily to determine the potential factors associated with remission. MATERIALS AND

methodsWe retrospectively reviewed the clinical records of patients with T2D who underwent radical gastrectomy for gastric cancer, from January 2008 to December 2012.

resultsT2D improved in 39 out of 70 (55.7%) patients at the postoperative 2-year follow-up and 21 of 42 (50.0%) at the 5-year follow-up. In the 2-year data analysis, preoperative body mass index (BMI) (P=0.043), glycated hemoglobin (A1C) level (P=0.039), number of anti-diabetic medications at baseline (P=0.040), reconstruction method (statistical difference was noted between Roux-en-Y reconstruction and Billroth I; P=0.035) were significantly related to the improvement in glycemic control. Unlike the results at 2 years, the 5-year data analysis revealed that only preoperative BMI (P=0.043) and A1C level (P=0.039) were statistically significant for the improvement in glycemic control; however, the reconstruction method was not.

conclusionsAll types of gastric cancer surgery can be effective in short- and long-term T2D control in non-obese patients. In addition, unless long-limb bypass is considered in gastric cancer surgery, the long-term glycemic control is not expected to be different between the reconstruction methods.

Indexed as

ControlGlycemic indexReconstruction methodStomach neoplasmsSurgeryType 2 diabetes mellitus

Identifiers

PMID29302369
PMCPMC5746650
OpenAlexW2769939462

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.